{
    "nct_id": "NCT05741502",
    "official_title": "An Exploratory Analysis of Immune and Inflammatory Response Associated with Clozapine Versus Non-Clozapine Antipsychotics in Individuals with Treatment-resistant Schizophrenia",
    "inclusion_criteria": "* All participants:\n\n  * Between 18 and 65 years of age\n  * Physically healthy (no clinically significant unstable medical condition as confirmed by medical history and physical examination)\n  * Able to give informed consent\n  * Treatment-Refractory Schizophrenia\n\nClozapine treatment group (n = 30) Individuals treated with Clozapine consistently for a minimum of 6 months\n\nNon-Clozapine treatment group Continued treatment with non-Clozapine antipsychotic but would be eligible for Clozapine with the provider/patient electing to not pursue such for clinical reasons, consistently treated for at least 6 months\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 65 Years",
    "exclusion_criteria": "* Clinically significant medical condition; cardiovascular, pulmonary, endocrine, or renal condition requiring in depth medical treatment\n* Active or recent (within 4 weeks) bacterial or viral infection\n* Chronic viral infection (hepatitis, HIV)\n* History of autoimmune, or chronic inflammatory condition\n* Current treatment with lithium\n* Treatment with Clozapine in the past 6 months\n* Current treatment with immunomodulatory or anti-inflammatory therapy\n* Vaccination within the past 3 months\n* Current alcohol or substance use disorder of moderate or severe severity\n* Intellectual disability (i.e. intelligence quotient <70)\n* Unwilling or unable to sign informed consent document\n* Pregnancy\n* Any patient deemed ineligible by PI discretion",
    "miscellaneous_criteria": ""
}